Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Warner-Lambert discloses another series of anticoagulants

Oct. 28, 1999

Warner-Lambert patents new anticoagulants with quinolinone structure

Oct. 27, 1999

First approval obtained for bivalirudin

Oct. 26, 1999

LMW heparin to be marketed in U.K. and Ireland by ICN

Oct. 26, 1999

New anticoagulants in the pipeline at DuPont

Oct. 25, 1999

Essex Pharma launches clot buster in Germany

Oct. 20, 1999

Merck's new fibrinogen receptor antagonists disclosed in recent patent

Oct. 14, 1999

BCH-2763 shows antithrombotic activity in canine model of DVT

Oct. 8, 1999

Pharming awarded grants for human lactoferrin research; announces collaboration

Oct. 5, 1999

New sulfonamide anticoagulants in the Takeda pipeline

Sep. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...